Neuraxis Inc (NRXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,801 | -6,092 | -3,969 | -2,279 | -8,242 |
| Depreciation Amortization | 60 | 35 | 19 | 6 | 164 |
| Accounts receivable | 47 | 134 | 116 | 1 | -179 |
| Accounts payable and accrued liabilities | -458 | 290 | -132 | -62 | -607 |
| Other Working Capital | 610 | 1,047 | 561 | 550 | 141 |
| Other Operating Activity | 1,109 | 88 | 334 | 179 | 2,624 |
| Operating Cash Flow | $-6,433 | $-4,499 | $-3,071 | $-1,604 | $-6,098 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -25 | -25 | -18 | -28 |
| Purchase Sale Intangibles | -100 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -100 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-131 | $-25 | $-25 | $-18 | $-28 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 0 | 0 | 4,935 |
| Debt Repayment | -282 | -225 | -155 | -70 | -276 |
| Common Stock Issued | 8,827 | 6,003 | 6,003 | 0 | 26 |
| Other Financing Activity | -713 | -574 | -460 | 0 | 5,059 |
| Financing Cash Flow | $7,832 | $5,204 | $5,388 | $-70 | $9,744 |
| Beginning Cash Position | 3,697 | 3,697 | 3,697 | 3,697 | 79 |
| End Cash Position | 4,965 | 4,377 | 5,989 | 2,005 | 3,697 |
| Net Cash Flow | $1,268 | $680 | $2,292 | $-1,692 | $3,618 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,433 | -4,499 | -3,071 | -1,604 | -6,098 |
| Capital Expenditure | -31 | -25 | -25 | -18 | -28 |
| Free Cash Flow | -6,464 | -4,524 | -3,096 | -1,622 | -6,126 |